These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 9376548)
1. [Volumetric and morphological CT parameters for assessing prognosis and treatment control in hepatocellular carcinoma undergoing arterial chemoembolization]. Vogl TJ; Trapp M; Pegios W; Mack M; Bechstein WO; Keck W; Scholz A; Schröder H; Neuhaus P; Felix R Rofo; 1997 Sep; 167(3):219-26. PubMed ID: 9376548 [TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580 [TBL] [Abstract][Full Text] [Related]
3. [Multi-sequential arterial chemoembolization of advanced hepatocellular carcinomas: computerized tomography follow-up parameters for evaluating effectiveness of therapy]. Vogl TJ; Schroeder H; Trapp M; Straub R; Schuster A; Schuster M; Mack M; Souchon F; Neuhaus P Rofo; 2000 Jan; 172(1):43-50. PubMed ID: 10719462 [TBL] [Abstract][Full Text] [Related]
4. [Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study]. Gattoni F; Cornalba G; Brambilla G; Dova S; Pompili G; Rampoldi A; Damiani G; Carnevali G; Uslenghi CM Radiol Med; 1998 Apr; 95(4):362-8. PubMed ID: 9676217 [TBL] [Abstract][Full Text] [Related]
5. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069 [TBL] [Abstract][Full Text] [Related]
7. Oily chemoembolization combined with degradable starch microspheres for HCC with cirrhosis. Murata S; Tajima H; Ichikawa K; Onozawa S; Wang J; Kumita S; Nomura K Hepatogastroenterology; 2008; 55(84):1041-6. PubMed ID: 18705325 [TBL] [Abstract][Full Text] [Related]
8. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion. Kamada K; Nakanishi T; Kitamoto M; Aikata H; Kawakami Y; Ito K; Asahara T; Kajiyama G J Vasc Interv Radiol; 2001 Jul; 12(7):847-54. PubMed ID: 11435541 [TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival. Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248 [TBL] [Abstract][Full Text] [Related]
10. Acute respiratory distress syndrome after transcatheter arterial chemoembolization of hepatocellular carcinomas. Wu GC; Perng WC; Chen CW; Chian CF; Peng CK; Su WL Am J Med Sci; 2009 Nov; 338(5):357-60. PubMed ID: 19826242 [TBL] [Abstract][Full Text] [Related]
11. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients. Hayashi K; Ina H; Tezuka M; Okada Y; Irie T Cardiovasc Intervent Radiol; 2007; 30(6):1144-55. PubMed ID: 17909884 [TBL] [Abstract][Full Text] [Related]
12. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session]. El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077 [TBL] [Abstract][Full Text] [Related]
13. Dense parenchymal accumulation of Lipiodol after transarterial chemoembolization. Hihara T; Araki T; Kachi K; Monzawa S; Uchiyama G Radiat Med; 1992; 10(3):79-81. PubMed ID: 1324510 [TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215 [TBL] [Abstract][Full Text] [Related]
15. [Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma]. Inoue H; Miyazono N; Kanetsuki I; Hori A; Tanaka D; Fukukura Y; Matsumoto Y; Nishida H; Ueno K; Nakajo M Gan To Kagaku Ryoho; 1993 Oct; 20(13):1973-6. PubMed ID: 7692822 [TBL] [Abstract][Full Text] [Related]
16. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599 [TBL] [Abstract][Full Text] [Related]
17. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria. Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990 [TBL] [Abstract][Full Text] [Related]
18. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy. Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921 [TBL] [Abstract][Full Text] [Related]
19. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. Matsuo N; Uchida H; Sakaguchi H; Nishimine K; Nishimura Y; Hirohashi S; Ohishi H Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-61-S6-70. PubMed ID: 9151919 [TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma. Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]